A nurse is caring for a client with bone metastases from breast cancer who is experiencing severe breakthrough pain despite receiving around-the-clock morphine. Which nursing action should be the priority?

Breakthrough pain requires immediate administration of prescribed short-acting opioids, followed by reassessment for safety and efficacy. Other options (increasing dose without orders, non-pharmacologic methods alone, or heat therapy) are unsafe or insufficient for severe breakthrough pain.

Understanding Breakthrough Cancer Pain (BTCP)
In clients with bone metastases, cancer cells infiltrate bone tissue, disrupting normal remodeling and releasing inflammatory mediators that sensitize nociceptors. This creates a constant, dull background pain managed by around-the-clock (ATC) opioids. Breakthrough cancer pain (BTCP) is a transient, severe flare of pain that erupts despite otherwise stable background pain control . Recognizing this distinction is critical for safe, effective nursing intervention. The immediate priority is rapid relief of this severe exacerbation to reduce suffering and prevent the negative physiological consequences of unrelieved pain.

Analysis of Priority Action
The correct priority action is to administer the prescribed short-acting opioid for breakthrough pain and reassess. This aligns with the foundational principle of using a multimodal treatment plan where ATC opioids manage baseline pain, and immediate-release "rescue" doses are specifically prescribed for BTCP episodes ^[2]. The nurse's role in a nurse-led pain management model involves timely assessment, administration of the correct rescue medication, and subsequent reassessment to evaluate effectiveness and monitor for adverse effects like sedation and respiratory depression .

Why Other Options Are Incorrect
- Option 1: Administer an additional dose of the scheduled long-acting morphine immediately. This is dangerous and outside the scope of nursing practice. Long-acting formulations are not designed for rapid onset and administering an extra dose can lead to overdose, severe sedation, and life-threatening respiratory depression due to drug accumulation. The cornerstone of BTCP management is a separate, fast-acting rescue opioid, not an increase in the long-acting agent ^[2].
- Option 3: Apply a heating pad to the most painful bone sites for 20 minutes. While physical modalities can be part of a comprehensive pain plan, they are not the priority for severe, acute breakthrough pain. Furthermore, applying heat directly over a tumor site is contraindicated as it may increase blood flow and potentially promote tumor growth or cause local tissue injury. This intervention does not address the immediate, severe pain crisis.
- Option 4: Teach the client to use guided imagery and relaxation techniques for pain. Psychoeducation and cognitive-behavioral strategies are valuable components of long-term pain self-management, as supported by mobile health interventions that offer tailored psychoeducation . However, in a moment of severe breakthrough pain, a client cannot effectively engage in learning or apply complex relaxation techniques. Pharmacological intervention must take precedence to bring the pain to a tolerable level first.

Clinical Application and Reassessment
After administering the rescue opioid, the nurse must reassess the client's pain level and sedation status within 15-30 minutes, corresponding to the peak effect time for most oral immediate-release opioids. This reassessment is a core component of effective pain management models, ensuring the intervention was effective and allowing for timely escalation or adjustment if the pain remains unrelieved . This process also helps address the common shortcomings of opioid therapy, such as inadequate relief in refractory cases, by providing data needed for potential adjustments to the multimodal plan ^[2]. The goal is to optimize pain control while vigilantly monitoring for side effects, thus improving the client's overall quality of life.